Elsevier

Clinical Biochemistry

Volume 45, Issue 12, August 2012, Pages 863-873
Clinical Biochemistry

Review
An overview of the regulation of bone remodelling at the cellular level

https://doi.org/10.1016/j.clinbiochem.2012.03.021Get rights and content

Abstract

Objectives

To review the current literature on the regulation of bone remodelling at the cellular level.

Design and methods

The cellular activities of the cells in the basic multicellular unit (BMU) were evaluated.

Results

Bone remodelling requires an intimate cross-talk between osteoclasts and osteoblasts and is tightly coordinated by regulatory proteins that interact through complex autocrine/paracrine mechanisms. Osteocytes, bone lining cells, osteomacs, and vascular endothelial cells also regulate bone remodelling in the BMU via cell signalling networks of ligand–receptor complexes. In addition, through secreted and membrane-bound factors in the bone microenvironment, T and B lymphocytes mediate bone homeostasis in osteoimmunology.

Conclusions

Osteoporosis and other bone diseases occur because multicellular communication within the BMU is disrupted. Understanding the cellular and molecular basis of bone remodelling and the discovery of novel paracrine or coupling factors, such as RANKL, sclerostin, EGFL6 and semaphorin 4D, will lay the foundation for drug development against bone diseases.

Highlights

► Bone remodelling is a complex process involving multiple cell types. ► Cells involved produce various cytokines that have autocrine and paracrine activity. ► Multicellular communication is important for control of bone remodelling. ► Aberrant remodelling results in diseases such as osteoporosis and Paget's disease.

Introduction

Bone is a rigid yet dynamic organ that is characterised as a type of connective tissue. Biochemically, it is defined by a mixture of inorganic elements and an organic matrix. In order to maintain its structural integrity, and to fulfil its role in mineral homeostasis, bone is continuously moulded, shaped and repaired, a process termed remodelling. Bone remodelling is the predominant metabolic process regulating bone structure and function during adult life [1], [2]. Remodelling is a complex, tightly regulated process carried out by two key cell types: osteoclasts and osteoblasts. Osteoclasts are the principal resorptive cell of bone, playing a role in the formation of the skeleton and regulation of bone mass. Osteoblasts are specialised bone forming cells that synthesise bone matrix, regulate mineralisation and finally differentiate into osteocytes or bone lining cells. The cellular coupling between the activities of the osteoclasts and osteoblasts is highly regulated by local and systemic factors to maintain bone homeostasis [3]. An imbalance in the bone remodelling process, favouring either osteoclast or osteoblast activity, leads to a number of clinical disease conditions including osteopenia, osteoporosis and osteopetrosis. The exact mechanisms responsible for aberrant bone remodelling are still largely unclear. Therefore, understanding the cellular and molecular mechanisms involved in bone remodelling may provide important insight(s) for therapeutic development.

Section snippets

The bone remodelling unit

Bone remodelling occurs through the concerted action of a functional cohort of cells termed the basic multicellular unit (BMU). The BMU consists of the osteoclasts resorbing bone, the osteoblasts replacing bone, the osteocytes within the bone matrix, the bone lining cells covering the bone surface and the capillary blood supply (Fig. 1). The remodelling cycle begins with an initiation phase that includes the recruitment of osteoclast precursors, their differentiation into mature osteoclasts as

Osteoclasts

Osteoclasts are multinucleated, giant cells formed by the fusion of mononuclear progenitors of the monocyte/macrophage family in a process termed osteoclastogenesis [2]. Osteoclasts are located on endosteal surfaces within the Haversian system and on the periosteal surface beneath the periosteum. Osteoclasts are usually rare cells in the bone with only two to three per μm3 [7]. Osteoclasts exist in two functional states, the motile and the resorptive phases. During the motile state they migrate

Osteoblasts

Osteoblasts are the only cell type responsible for bone formation. They originate from mesenchymal stem cells that have the potential to differentiate into mature osteoblasts [49], [50]. There are four maturational stages that have been identified in osteoblast differentiation: the preosteoblast, osteoblast, osteocyte and bone-lining cell. Provided the appropriate stimuli are present, the mesenchymal stem cells form preosteoblasts. Histologically these cells resemble osteoblasts and stain

Osteocytes

Osteocytes are terminally differentiated osteoblasts that incorporate into the newly formed bone matrix [82]. These cells are smaller than osteoblasts and have lost many of their cytoplasmic organelles [83]. Osteocytes lie within lacunae in the newly formed bone matrix where they reside for long periods of time but ultimately undergo apoptosis. Osteocytes are spatially isolated from one another; however, they extend long filipodial extensions, which are rich in actin cytoskeleton, connecting

Bone lining cells

A subset of osteoblasts will differentiate into bone lining cells. These cells line the majority of bone surfaces that are not being remodelled. It has been proposed that bone lining cells play a role in bone remodelling by preventing the inappropriate interaction of osteoclast precursors with the bone surface. It is thought that the signals that initiate osteoclast formation may stimulate the bone lining cells to prepare for bone resorption, through the actions of collagenase which digests a

Osteomacs

Osteomacs are resident tissue macrophages present on or near the periosteal and endosteal surfaces. They are located within three cells of a bone surface and are often intercalated or associated with bone lining cells. During bone modelling osteomacs form a canopy-like structure over mature osteoblasts [99], [100]. Osteomacs regulate osteoblast mineralisation as evidenced by in vitro and in vivo studies showing that depletion of osteomac populations results in reduced osteoblast mineralisation

Vascular endothelial cells

A vital, but often overlooked, component of the BMU is the capillary that supplies oxygen and nutrients, and removes calcium and waste products of resorption. Bone is one of the most highly vascularized tissues and angiogenesis plays a pivotal role in bone formation, remodelling and healing [98], [103]. The blood supply to bone is essential for maintenance of bone mineral density and bone structure. Pathological situations resulting in loss of the bone blood supply lead to bone death, such as

Lymphocytes — T cells and B cells

The relationship between the immune and skeletal systems has been studied since the early 1970s and as such the term osteoimmunology was created to describe the overlap between these fields (for a detailed review on osteoimmunology see [121]). Given that immune cells and haematopoietic cells originate in the bone marrow it is not surprising that there is cross-talk between the two systems. A number of factors secreted by immune cells are also known to be osteoclast activating such as RANKL

Diseases due to aberrant bone remodelling

The maintenance of bone homeostasis is dependent on the balance of cellular activities during bone remodelling. Disruption to the balanced regulation of bone remodelling results in a number of disease conditions including osteoporosis, osteopetrosis and Paget's disease of bone.

Conclusion

The process of bone remodelling is tightly coordinated by a myriad of cellular activities. Whilst intimate cross-talk between osteoblasts and osteoclasts is an integral element in bone remodelling, other cells including osteocytes, bone lining cells, osteomacs and endothelial cells of the basic multicellular unit also play an important part. An imbalance of these cellular activities often contributes to bone diseases such as osteoporosis and osteopetrosis or leads to bone growth deformities.

Conflict of interest

No conflict of interest.

Acknowledgements

This work was funded in part by National Health and Medical Research Council of Australia and Sir Charles Gairdner Hospital Research Fund.

References (161)

  • T.J. Martin et al.

    Osteoclast-derived activity in the coupling of bone formation to resorption

    Trends Mol Med

    (2005)
  • C. Gray et al.

    Topographically induced bone formation in vitro: implications for bone implants and bone grafts

    Bone

    (1996)
  • U. Kornak et al.

    Loss of the clc-7 chloride channel leads to osteopetrosis in mice and man

    Cell

    (2001)
  • M.A. Karsdal et al.

    Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption

    Am J Pathol

    (2005)
  • M.M. Guerrini et al.

    Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to tnfrsf11a (rank) mutations

    Am J Hum Genet

    (2008)
  • C. Zhao et al.

    Bidirectional ephrinb2-ephb4 signaling controls bone homeostasis

    Cell Metab

    (2006)
  • H. Huang et al.

    Wnt/beta-catenin signaling: new (and old) players and new insights

    Curr Opin Cell Biol

    (2008)
  • J. Westendorf et al.

    Wnt signaling in osteoblasts and bone diseases

    Gene

    (2004)
  • Y. Gong et al.

    Ldl receptor-related protein 5 (lrp5) affects bone accrual and eye development

    Cell

    (2001)
  • R.D. Little et al.

    A mutation in the ldl receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

    Am J Hum Genet

    (2002)
  • L. Van Wesenbeeck et al.

    Six novel missense mutations in the ldl receptor-related protein 5 (lrp5) gene in different conditions with an increased bone density

    Am J Hum Genet

    (2003)
  • T. Matsunobu et al.

    Critical roles of the tgf-beta type 1 receptor alk5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development

    Dev Biol

    (2009)
  • N. Takahashi et al.

    A new member of tumor necrosis factor ligand family, odf/opgl/trance/rankl, regulates osteoclast differentiation and function

    Biochem Biophys Res Commun

    (1999)
  • X. Li et al.

    Parathyroid hormone stimulates osteoblastic expression of mcp-1 to recruit and increase the fusion of pre/osteoclasts

    J Biol Chem

    (2007)
  • S. Tatsumi et al.

    Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction

    Cell Metab

    (2007)
  • X. Li et al.

    Sclerostin binds to lrp5/6 and antagonizes canonical wnt signaling

    J Biol Chem

    (2005)
  • W. Boyle et al.

    Osteoclast differentiation and activation

    Nature

    (2003)
  • S.L. Teitelbaum

    Bone resorption by osteoclasts

    Science

    (2000)
  • P. Hill

    Bone remodelling

    Br J Orthod

    (1998)
  • G.D. Roodman

    Advances in bone biology: the osteoclast

    Endocr Rev

    (1996)
  • H.K. Vaananen et al.

    The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure

    J Cell Sci

    (1995)
  • N. Udagawa et al.

    Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

    Proc Natl Acad Sci U S A

    (1990)
  • R. Felix et al.

    Role of colony-stimulating factor-1 in bone metabolism

    J Cell Biochem

    (1994)
  • J.M. Hodge et al.

    Multiple roles of m-csf in human osteoclastogenesis

    J Cell Biochem

    (2007)
  • F.P. Ross

    M-csf, c-fms, and signaling in osteoclasts and their precursors

    Ann N Y Acad Sci

    (2006)
  • M.M. Tondravi et al.

    Osteopetrosis in mice lacking haematopoietic transcription factor pu.1

    Nature

    (1997)
  • A.E. Grigoriadis et al.

    C-fos: a key regulator of osteoclast–macrophage lineage determination and bone remodeling

    Science

    (1994)
  • H. Yoshida et al.

    The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

    Nature

    (1990)
  • S.K. Begg et al.

    Delayed hematopoietic development in osteopetrotic (op/op) mice

    J Exp Med

    (1993)
  • T.L. Burgess et al.

    The ligand for osteoprotegerin (opgl) directly activates mature osteoclasts

    J Cell Biol

    (1999)
  • J. Xu et al.

    Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of nf-kappab ligand

    J Bone Miner Res

    (2000)
  • J. Lam et al.

    Crystal structure of the trance/rankl cytokine reveals determinants of receptor-ligand specificity

    J Clin Invest

    (2001)
  • P. Kostenuik et al.

    Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

    Curr Pharm Des

    (2001)
  • T. Koga et al.

    Costimulatory signals mediated by the itam motif cooperate with rankl for bone homeostasis

    Nature

    (2004)
  • E.S.M. Ang et al.

    Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa b ligand (rankl)

    J Cell Physiol

    (2007)
  • K. Sato et al.

    Regulation of osteoclast differentiation and function by the camk-creb pathway

    Nat Med

    (2006)
  • A.R. Hayman et al.

    Mice lacking tartrate-resistant acid phosphatase (acp 5) have disrupted endochondral ossification and mild osteopetrosis

    Development

    (1996)
  • H. Roberts et al.

    Altered collagen in tartrate-resistant acid phosphatase (trap)-deficient mice: a role for trap in bone collagen metabolism

    Calcif Tissue Int

    (2007)
  • M. Centrella et al.

    Transforming growth factor-beta and remodeling of bone

    J Bone Joint Surg Am

    (1991)
  • J.M. Hayden et al.

    The insulin-like growth factor system and the coupling of formation to resorption

    Bone

    (1995)
  • Cited by (385)

    View all citing articles on Scopus
    View full text